Results 201 to 210 of about 364,170 (283)

Could eggshell membrane be an adjuvant for recombinant Hepatitis B vaccine?: A preliminary investigation. [PDF]

open access: yesFutur J Pharm Sci, 2023
Joshua PE   +5 more
europepmc   +1 more source

Hepatitis B Vaccine and Multiple Sclerosis: Cause or Coincidence. [PDF]

open access: yesCureus, 2022
Luhadia K   +5 more
europepmc   +1 more source

Management of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: consensus statement

open access: yesMedical Journal of Australia, EarlyView.
Abstract Introduction Buruli ulcer, caused by Mycobacterium ulcerans, is increasing in incidence and spreading to new areas in southeast Australia. With increasing experience and emerging evidence, this consensus statement considers contemporary data to provide up‐to‐date recommendations to clinicians who may encounter this disease.
Stephen Muhi   +15 more
wiley   +1 more source

Characteristic, Regulation and Targeting Strategies of Cancer Stem Cells and Their Niche in Digestive System Tumors

open access: yesMedComm – Oncology, Volume 4, Issue 2, June 2025.
Cancer stem cells, characterized by self‐renewal, differentiation, heterogeneity, plasticity and tumorigenicity, are regulated by intrinsic factors such as signaling pathways, transcription factors, metabolism and noncoding RNAs, as well as environmental cells (including tumor cells, immune cells and stromal cells), environmental factors and distant ...
Zhenzhen Chen   +11 more
wiley   +1 more source

Scientific approaches to defining HPV vaccine‐induced protective immunity

open access: yesInternational Journal of Cancer, Volume 156, Issue 10, Page 1848-1857, 15 May 2025.
Abstract Seventeen years after the licensure of prophylactic human papillomavirus (HPV) L1 virus‐like‐particle vaccines, a defined antibody level that correlates with vaccine‐induced protection against HPV infections and associated neoplasia is missing.
Matti Lehtinen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy